The Basics

Introduction

Colorectal cancer is a well-known and commonly diagnosed condition that affects both men and women, usually at age 50 or above. Cancer of the colon or rectum will be the third most commonly diagnosed type of cancer for both men and women in the United States in 2007. 

Colorectal cancer starts either in the colon or rectum. Because cancer of the colon (colon cancer) and cancer of the rectum (rectal cancer) have many common features they are often simply called "colorectal cancer." Other names for this condition are cancer of the large intestine and cancer of the large bowel.

The colon and rectum are part of the large intestine—a long, thick, winding tube that performs the final steps in digesting food. The colon forms most of the large intestine. It soaks up water and minerals from food, converts food to waste, and allows it to exit the body. The rectum is the last segment of the large intestine. It holds solid waste until it leaves the body through the anus as part of a bowel movement.

Although the exact causes of most colorectal cancers are unknown, certain risk factors have been identified. These include older age, ulcerative colitis (a disease causing inflammation of the colon), and a previous or family history of colorectal cancer. Most colorectal tumors begin as noncancerous (benign) polyps on the wall of the colon or rectum.

This content was last modified on October 11, 2007 .

Latest Colon Cancer News

  • May 16, 2008
    Vitamin D may lower breast cancer risk
    WASHINGTON (Reuters) - Breast cancer patients with lower levels of vitamin D were far more likely to die and far more likely to have their cancer spread than women with normal levels, Canadian researchers reported on Thursday.
  • May 16, 2008
    Rash most common side effect in Vectibix trials
    LOS ANGELES (Reuters) - The most common side effect observed in ongoing trials of Amgen Inc's cancer drug Vectibix is skin rash, according to interim analyses of pivotal trials of the drug in colorectal cancer released on Thursday.
  • May 9, 2008
    Colon Cancer Outcomes Differ Between Men and Women
    Variations within the gene responsible for epidermal growth factor receptors (EGFR) may be predictive of differing outcomes between male and female patients diagnosed with metastatic colon cancer. Details of the study have recently been published in the Journal of Cancer Research.
Select news items provided by Reuters Health
More Cancer News

Privacy Policy reviewed by TRUSTe

This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health
Information:
verify here.

Secure transactions for this website use a thawte certificate to ensure secure transmission of your information.